In a study conducted at the University of Pittsburgh, 35 female rhesus monkeys were exposed to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an effort to establish a plausible animal model for Parkinson;;s disease progression and treatment using neurotrophic factors. In addition to standard clinical measurements of Parkinson;;s severity, actigraphy devices recording minute level activity weret to each of the monkeys. This thesis primarily aims to understand how activity patterns in healthy subjectscan predict their susceptibility to developing Parkinson;;s-like symptoms as a resultof MPTP exposure. Secondarily, we show how subjects respond to neurotrophic factorsin terms of both subjects;; activity and through standard clinical metrics.